 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Alere Provides Update on Commercialization Timeline for Nucleic Acid-Based Testing Platforms
February 28, 2013
Alere Provides Update on Commercialization Timeline for Nucleic Acid-Based Testing Platforms
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Alere Developing Pair of NAT Platforms with Initial Assays Planned for HIV Viral Load, Flu
May 17, 2012 / PCR Insider - Alere Garners Up to $42.2M in Grants and Loans from Gates Foundation for POC MDx Platforms
March 1, 2013 / GenomeWeb Daily News - GenomeWeb Feature: Tools for Point-of-Care MDx Available, but Challenges Still Loom
February 28, 2013 / PCR Insider - Isothermal Assay from PATH, Hutch, TwistDx Rapidly Detects Multiple HIV-1 Subtypes
April 4, 2013 / PCR Insider - PATH Using TwistDx's Amplification Tech in Minimally Instrumented HIV Test for Infants
August 25, 2011 / PCR Insider